5, PP 989-994 [online] Available at: (accessed 7 th April 2022) Gao, X., Sanderson, S.M., Dai, Z., Reid, M.A., Cooper, D.E., Lu, M., Richie, J.P., Ciccarella, A., Calcagnotto, A., Mikhael, P.G., Mentch, S.J., Liu, J., Ables, G., Kirsch, D.G., Hsu, D.S., Nichenametia, S.N
While often temporary, this increase in platelets carries serious risks: Deep vein thrombosis (blood clots in deep veins, usually in legs) Pulmonary embolism (blood clots in lungs) Arterial thrombosis (clots in arteries) Cerebrovascular events (strokes) Coronary artery thrombosis (heart attacks) Splanchnic vein thrombosis (clots in abdominal veins) The risk is particularly high in: Elderly patients Those with pre-existing heart disease Patients with inherited blood-clotting disorders Immobilized individuals Those with hardened arteries Neurological Symptoms and Joint Pain Paradoxically, B12 replacement can temporarily worsen or trigger new neurological symptoms
Lot-traced COA on file Sterility & mycoplasma tested PEPTIDE DOSE: Select dose DRAW SYRINGE TO: Select values YOUR VIAL CONTAINS: Select values CONCENTRATION: Select values The PT-141 10mg is a research-grade peptide formulation intended exclusively for laboratory and scientific research applications
Discontinue if irritation occurs
These injections offer a comprehensive approach to weight management, fostering sustainable outcomes and enhancing overall well-being
What about cost